Screening for pancreatic neoplasia in high-risk individuals: An EUS-based approach

Clinical Gastroenterology and Hepatology

Volumn 2, Issue 7, 2004, Pages 606-621

  Canto, Marcia Irene ^a,c   Goggins, Michael ^a   Yeo, Charles J ^a   Griffin, Constance ^a   Axilbund, Jennifer E ^a   Brune, Kieran ^a   Ali, Syed Z ^a   Jagannath, Sanjay ^a   Petersen, Gloria M ^b   Fishman, Elliot K ^a   Piantadosi, Steven ^a   Giardiello, Francis M ^a   Hruban, Ralph H ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MAYO CLINIC   (United States)

^c NONE   (United States)

Author keywords

computed tomography; CT; endoscopic retrograde cholangiopancreatography; endoscopic ultrasonography; ERCP; EUS; fine needle aspiration; FNA; intraductal papillary mucinous neoplasm; IPMN; National Familial Pancreas Tumor Registry; NFPTR; PanIN

Indexed keywords

ALCOHOL;

ADENOCARCINOMA; ADULT; ALCOHOL CONSUMPTION; ANAMNESIS; ARTICLE; ASPIRATION BIOPSY; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTADENOMA; DIAGNOSTIC PROCEDURE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPY; EVALUATION; FAMILIAL CANCER; FEMALE; GASTROINTESTINAL DISEASE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MALE; PANCREAS CARCINOMA; PANCREAS TUMOR; PATIENT REFERRAL; PEUTZ JEGHERS SYNDROME; PROSPECTIVE STUDY; RELATIVE; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; ULTRASOUND; UPPER GASTROINTESTINAL TRACT;

AGE DISTRIBUTION; AGED; BIOPSY, NEEDLE; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; ENDOSONOGRAPHY; FEASIBILITY STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; PANCREATIC NEOPLASMS; PATIENT COMPLIANCE; PEDIGREE; PREVALENCE; PROBABILITY; PROGNOSIS; PROGRAM EVALUATION; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3042525898     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(04)00244-7     Document Type: Article

References (66)

1. Ghadirian P., Boyle P., Simard A., Baillargeon J., Maisonneuve P., Perret C. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol. 10:1991;183-196
2. Lal G., Liu G., Schmocker B., Kaurah P., Ozcelik H., Narod S.A., Redston M., Gallinger S. Inherited predisposition to pancreatic adenocarcinoma role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res. 60:2000;409-416
3. Hahn S.A., Greenhalf B., Ellis I., Sina-Frey M., Rieder H., Korte B., Gerdes B., Kress R., Ziegler A., Raeburn J.A., Campra D., Grutzmann R., Rehder H., Rothmund M., Schmiegel W., Neoptolemos J.P., Bartsch D.K. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst. 95:2003;214-221
4. Murphy K.M., Brune K.A., Griffin C., Sollenberger J.E., Petersen G.M., Bansal R., Hruban R.H., Kern S.E. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer deleterious BRCA2 mutations in 17%. Cancer Res. 62:2002;3789-3793
5. Goggins M., Schutte M., Lu J., Moskaluk C.A., Weinstein C.L., Petersen G.M., Yeo C.J., Jackson C.E., Lynch H.T., Hruban R.H., Kern S.E. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 56:1996;5360-5364
6. Bartsch D.K., Sina-Frey M., Lang S., Wild A., Gerdes B., Barth P., Kress R., Grutzmann R., Colombo-Benkmann M., Ziegler A., Hahn S.A., Rothmund M., Rieder H. CDKN2A germline mutations in familial pancreatic cancer. Ann Surg. 236:2002;730-737
7. Vasen H.F., Gruis N.A., Frants R.R., van Der Velden P.A., Hille E.T., Bergman W. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer. 87:2000;809-811
8. Gruber S.B., Entius M.M., Petersen G.M., Laken S.J., Longo P.A., Boyer R., Levin A.M., Mujumdar U.J., Trent J.M., Kinzler K.W., Vogelstein B., Hamilton S.R., Polymeropoulos M.H., Offerhaus G.J., Giardiello F.M. Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res. 58:1998;5267-5270
9. van der Heijden M.S., Yeo C.J., Hruban R.H., Kern S.E. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res. 63:2003;2585-2588
10. Rogers C., van der Heijden M.S., Brune K., Yeo C., Hruban R.H., Kern S.E., Goggins M. The genetics of FANCC and FANCG in familial pancreatic cancer. Cancer Biol Ther. 3:2004;167-169
11. Lowenfels A.B., Maisonneuve P., DiMagno E.P., Elitsur Y., Gates L.K., Perrault J., Whitcomb D.C. International Hereditary Pancreatitis Study Group. Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst. 89:1997;442-446
12. Giardiello F.M., Brensinger J.D., Tersmette A.C., Goodman S.N., Petersen G.M., Booker S.V., Cruz-Correa M., Offerhaus J.A. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 119:2000;1447-1453
13. Lynch H.T., Fusaro R.M. Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome. Pancreas. 6:1991;127-131
14. Bergman W., Gruis N. Familial melanoma and pancreatic cancer. N Engl J Med. 334:1996;471-472
15. Goldstein A.M., Struewing J.P., Chidambaram A., Fraser M.C., Tucker M.A. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. J Natl Cancer Inst. 92:2000;1006-1010
16. Mantelli M., Barile M., Ciotti P., Ghiorzo P., Lantieri F., Pastorino L., Catricala C., Torre G.D., Folco U., Grammatico P., Padovani L., Pasini B., Rovini D., Queirolo P., Rainero M.L., Santi P.L., Sertoli R.M., Goldstein A.M., Bianchi-Scarra G. High prevalence of the G101W germline mutation in the CDKN2A P16(ink4a) gene in 62 Italian malignant melanoma families. Am J Med Genet. 107:2002;214-221
17. Hruban R.H., Petersen G.M., Ha P.K., Kern S.E. Genetics of pancreatic cancer. From genes to families. Surg Oncol Clin N Am. 7:1998;1-23
18. Klein A.P., Beaty T.H., Bailey-Wilson J.E., Brune K.A., Hruban R.H., Petersen G.M. Evidence for a major gene influencing risk of pancreatic cancer. Genet Epidemiol. 23:2002;133-149
19. Ozcelik H., Schmocker B., Di Nicola N., Shi X.H., Langer B., Moore M., Taylor B.R., Narod S.A., Darlington G., Andrulis I.L., Gallinger S., Redston M. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet. 16:1997;17-18
20. Eberle M.A., Pfutzer R., Pogue-Geile K.L., Bronner M.P., Crispin D., Kimmey M.B., Duerr R.H., Kruglyak L., Whitcomb D.C., Brentnall T.A. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. Am J Hum Genet. 70:2002;1044-1048
21. Tersmete A., Petersen G., Offerhaus G., Falatko F., Goggins M., Rosenblum E., Wilentz R., Yeo C., Cameron J., Kern S., Hruban R. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res. 7:2001;738-744
22. Klein A., Brune K., Petersen G.M., Goggins M., Tersmette A.C., Offerhaus G.J., Griffin C., Cameron J.L., Yeo C.J., Kern S., Hruban R.H. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 64:2004;2634-2638
23. Sahai A.V., Zimmerman M., Aabakken L., Tarnasky P.R., Cunningham J.T., van Velse A., Hawes R.H., Hoffman B.J. Prospective assessment of the ability of endoscopic ultrasound to diagnose, exclude, or establish the severity of chronic pancreatitis found by endoscopic retrograde cholangiopancreatography. Gastrointest Endosc. 48:1998;18-25
24. Catalano M.F., Lahoti S., Geenen J.E., Hogan W.J. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc. 48:1998;11-17
25. Wiersema M.J., Hawes R.H., Lehman G.A., Kochman M.L., Sherman S., Kopecky K.K. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin. Endoscopy. 25:1993;555-564
26. Hollerbach S., Klamann A., Topalidis T., Schmiegel W.H. Endoscopic ultrasonography (EUS) and fine-needle aspiration (FNA) cytology for diagnosis of chronic pancreatitis. Endoscopy. 33:2001;824-831
27. Brentnall T.A., Bronner M.P., Byrd D.R., Haggitt R.C., Kimmey M.B. Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med. 131:1999;247-255
28. Axon A.T. Endoscopic retrograde cholangiopancreatography in chronic pancreatitis. Cambridge classification. Radiol Clin North Am. 27:1989;39-50
29. Siegel S., Castellan N. Nonparametric statistics for the behavioral sciences. ed 2. 1988;McGraw Hill, New York
30. Boyle P., Maisonneuve P., Bueno de Mesquita B., Ghadirian P., Howe G.R., Zatonski W., Baghurst P., Moerman C.J., Simard A., Miller A.B., Przewoniak K., McMichael A.J., Hsieh C.C., Walker A.M. Cigarette smoking and pancreas cancer a case control study of the search programme of the IARC. Int J Cancer. 67:1996;63-71
31. Schenk M., Schwartz A.G., O'Neal E., Kinnard M.,., Greenson J.K., Fryzek J.P., Ying G.S., Garabrant D.H. Familial risk of pancreatic cancer. J Natl Cancer Inst. 93:2001;640-644
32. Rulyak S.J., Lowenfels A.B., Maisonneuve P., Brentnall T.A. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology. 124:2003;1292-1299
33. Tsunoda T., Yamamoto Y., Kimoto M., Imai H., Iwamoto S., Kawasaki S., Kawashima K., Tadaoka Y., Majima T., Onuma E., Iki K., Kubozoe T., Eto T. Staging and treatment for patients with pancreatic cancer. How small is an early pancreatic cancer? J Hepatobiliary Pancreat Surg. 5:1998;128-132
34. Sohn T.A., Yeo C.J., Cameron J.L., Koniaris L., Kaushal S., Abrams R.A., Sauter P.K., Coleman J., Hruban R.H., Lillemoe K.D. Resected adenocarcinoma of the pancreas-616 patients results, outcomes, and prognostic indicators. J Gastrointest Surg. 4:2000;567-579
35. Ariyama J., Suyama M., Ogawa K., Ikari T., Nagaiwa J., Fujii D., Tsuchida A. The detection and prognosis of small pancreatic carcinoma. Int J Pancreatol. 7:1990;37-47
36. American Gastroenterological Association. Medical position statement epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology. 117:1999;1463-1484
37. Lowenfels A.B., Maisonneuve P., Whitcomb D.C., Lerch M.M., DiMagno E.P. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA. 286:2001;169-170
38. Brown M.L., Houn F., Sickles E.A., Kessler L.G. Screening mammography in community practice positive predictive value of abnormal findings and yield of follow-up diagnostic procedures. AJR Am J Roentgenol. 165:1995;1373-1377
39. Kimmey M.B., Bronner M.P., Byrd D.R., Brentnall T.A. Screening and surveillance for hereditary pancreatic cancer. Gastrointest Endosc. 56:2002;S82-S86
40. Rulyak S.J., Kimmey M.B., Veenstra D.L., Brentnall T.A. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc. 57:2003;23-29
41. Legmann P., Vignaux O., Dousset B., Baraza A.J., Palazzo L., Dumontier I., Coste J., Louvel A., Roseau G., Couturier D., Bonnin A. Pancreatic tumors comparison of dual-phase helical CT and endoscopic sonography. AJR Am J Roentgenol. 170:1998;1315-1322
42. Falk R.T., Pickle L.W., Fontham E.T., Correa P., Fraumeni J.F. Jr. Life-style risk factors for pancreatic cancer in Louisiana a case-control study. Am J Epidemiol. 128:1988;324-336
43. Raut C.P., Grau A.M., Staerkel G.A., Kaw M., Tamm E.P., Wolff R.A., Vauthey J.N., Lee J.E., Pisters P.W., Evans D.B. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg. 7:2003;118-128
44. Rosch T., Meining A., Fruhmorgen S., Zillinger C., Schusdziarra V., Hellerhoff K., Classen M., Helmberger H. A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc. 55:2002;870-876
45. Ariyama J., Suyama M., Satoh K., Sai J. Imaging of small pancreatic ductal adenocarcinoma. Pancreas. 16:1998;396-401
46. Hruban R.H., Adsay N.V., Albores-Saavedra J., Compton C., Garrett E.S., Goodman S.N., Kern S.E., Klimstra D.S., Kloppel G., Longnecker D.S., Luttges J., Offerhaus G.J. Pancreatic intraepithelial neoplasia a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol. 25:2001;579-586
47. Pearson A.S., Chiao P., Zhang L., Zhang W., Larry L., Katz R.L., Evans D.B., Abbruzzese J.L. The detection of telomerase activity in patients with adenocarcinoma of the pancreas by fine needle aspiration. Int J Oncol. 17:2000;381-385
48. McCarthy D.M., Maitra A., Argani P., Rader A.E., Faigel D.O., Van Heek N.T., Hruban R.H., Wilentz R.E. Novel markers of pancreatic adenocarcinoma in fine-needle aspiration mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Appl Immunohistochem Mol Morphol. 11:2003;238-243
49. Ordonez N.G. Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol. 27:2003;1418-1428
50. Wiesenauer C.A., Schmidt C.M., Cummings O.W., Yiannoutsos C.T., Howard T.J., Wiebke E.A., Goulet R.J. Jr, McHenry L., Sherman S., Lehman G.A., Cramer H., Madura J.A. Preoperative predictors of malignancy in pancreatic intraductal papillary mucinous neoplasms. Arch Surg. 138:2003;610-618
51. Freeman M.L., Nelson D.B., Sherman S., Haber G.B., Herman M.E., Dorsher P.J., Moore J.P., Fennerty M.B., Ryan M.E., Shaw M.J., Lande J.D., Pheley A.M. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 335:1996;909-918
52. Fukushima N., Walter K.M., Uek T., Sato N., Matsubayashi H., Cameron J.L., Hruban R.H., Canto M., Yeo C.J., Goggins M. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice. Cancer Biol Ther. 2:2003;78-83
53. Rosty C., Christa L., Kuzdzal S., Baldwin W.M., Zahurak M.L., Carnot F., Chan D.W., Canto M., Lillemoe K.D., Cameron J.L., Yeo C.J., Hruban R.H., Goggins M. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res. 62:2002;1868-1875
54. Schima W., Fugger R., Schober E., Oettl C., Wamser P., Grabenwoger F., Ryan J.M., Novacek G. Diagnosis and staging of pancreatic cancer comparison of mangafodipir trisodium-enhanced MR imaging and contrast-enhanced helical hydro-CT. AJR Am J Roentgenol. 179:2002;717-724
55. Obuz F., Dicle O., Coker A., Sagol O., Karademir S. Pancreatic adenocarcinoma detection and staging with dynamic MR imaging. Eur J Radiol. 38:2001;146-150
56. Sheridan M.B., Ward J., Guthrie J.A., Spencer J.A., Craven C.M., Wilson D., Guillou P.J., Robinson P.J. Dynamic contrast-enhanced MR imaging and dual-phase helical CT in the preoperative assessment of suspected pancreatic cancer a comparative study with receiver operating characteristic analysis. AJR Am J Roentgenol. 173:1999;583-590
57. Albert J., Schilling D., Breer H., Jungius K.P., Riemann J.F., Adamek H.E. Mucinous cystadenomas and intraductal papillary mucinous tumors of the pancreas in magnetic resonance cholangiopancreatography. Endoscopy. 32:2000;472-476
58. Kahl S., Glasbrenner B., Leodolter A., Pross M., Schulz H.U., Malfertheiner P. EUS in the diagnosis of early chronic pancreatitis a prospective follow-up study. Gastrointest Endosc. 55:2002;507-511
59. Lowenfels A.B., Maisonneuve P., Cavallini G., Ammann R.W., Lankisch P.G., Andersen J.R., DiMagno E.P., Andren-Sandberg A., Domellof L. International Pancreatitis Study Group. Pancreatitis and the risk of pancreatic cancer. N Engl J Med. 328:1993;1433-1437
60. Weiss F.U., Simon P., Witt H., Mayerle J., Hlouschek V., Zimmer K.P., Schnekenburger J., Domschke W., Neoptolemos J.P., Lerch M.M. SPINK1 mutations and phenotypic expression in patients with pancreatitis associated with trypsinogen mutations. J Med Genet. 40:2003;e40
61. Witt H. Gene mutations in children with chronic pancreatitis. Pancreatology. 1:2001;432-438
62. Threadgold J., Greenhalf W., Ellis I., Howes N., Lerch M.M., Simon P., Jansen J., Charnley R., Laugier R., Frulloni L., Olah A., Delhaye M., Ihse I., Schaffalitzky de Muckadell O.B., Andren-Sandberg A., Imrie C.W., Martinek J., Gress T.M., Mountford R., Whitcomb D., Neoptolemos J.P. The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut. 50:2002;675-681
63. Matsubayashi H., Fukushima N., Sato N., Brune K., Canto M., Yeo C.J., Hruban R.H., Kern S., Goggins M. Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer. Cancer Biol Ther. 2:2003;652-655
64. Rajan E., Clain J.E., Levy M.J., Norton I.D., Vasquez-Sequieros E., Jondal M.L., Wiersema M.J. Prospective evaluation of age-related changes of the pancreas identified by endosonography. (abstr) Gastrointest Endosc. 55:2002;AB95
65. Hruban R.H., Canto M.I., Yeo C.J. Prevention of pancreatic cancer and strategies for management of familial pancreatic cancer. Dig Dis. 19:2001;76-84
66. Cuendet M., Pezzuto J.M. The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol Drug Interact. 17:2000;109-157